Space startup's CEO talks about putting tens of thousands of satellites in orbit to serve as networked data centers.

The song has been streamed over 3 million times in under a month. A song created through artificial intelligence has made history topping a Billboard country music chart, but it has also sent ...

I wanted to check if there is any MCP tool or API available that can be used to fetch the chart structure or the chart’s params field (i.e., the JSON parameters used for creating that chart) in Apache ...

As artificial intelligence drives the need for vastly more computing storage and processing power, interest in space-based data centers has spiked. Although several startup companies, such as ...

Reflect Orbital, which was founded in 2021, has recently taken the first step in a scheme to sell sunlight at night by bouncing solar rays off giant "reflectors" that can redirect the vital resource ...

These days, orbital real estate is growing increasingly cluttered with all manner of communication, observation, research, and navigation satellites. It’s a market worth $286 billion in 2022, ...

Reflect Orbital says their light-on-demand idea has generated significant interest from commercial and government customers. When you purchase through links on our site, we may earn an affiliate ...

INDIANAPOLIS -- Indianapolis Colts backup quarterback Anthony Richardson suffered an orbital fracture to his eye prior to Sunday's 31-27 victory over the Arizona Cardinals, according to coach Shane ...

There’s something weird in the water in Indianapolis lately. The Colts had a couple of unusual injuries during pregame warmups before Sunday’s win over the Cardinals. Cornerback Charvarius Ward ...

Oct 10 (Reuters) - Drugmaker Bristol Myers Squibb (BMY.N), opens new tab said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to ...

Bristol Myers Squibb (NYSE:BMY) has agreed to acquire privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash. Orbital Therapeutics is advancing a new generation of RNA ...

The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...